Intuitive Surgical (ISRG.US) Price Target 2026/2027: 30% Upside – Rating and Stock Analysis

373,98
-0,33%
Price history for Intuitive Surgical (ISRG.US) – stock price at 373.98 $, August 2026
Intuitive Surgical stock price – price development 2026. Updated Aug 6, 2026.
Share this analysis:

Intuitive Surgical Price Target 2026: Analysts See 28% Upside

The average price target for Intuitive Surgical is $477.25. This price target represents the analysts' view of the stock price over the next 12 months. The stock may be undervalued, because the price target is higher than the current price. The stock is 27,61% below the target, which can point to potential returns within the next 12 months if the analysts' view proves right. Also consider the stock's valuation ratios such as P/E, P/S and P/B, plus the technical analysis further down the page, for the full picture.

Is Intuitive Surgical overvalued or undervalued?

Intuitive Surgical is currently undervalued with a gap of 27.6% relative to the price target.


The current price is $373.98, which places Intuitive Surgical in the undervalued category. The stock is considered undervalued when the price is below $429.53, and overvalued when the price exceeds $524.98.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For Intuitive Surgical, the fair value range lies between $429.53 and $524.98.


See the full price target analysis for Intuitive Surgical →

Analyst Ratings for Intuitive Surgical stock in 2026: Buy

33 analysts cover Intuitive Surgical. The majority is positive, with 66.6% recommending Buy, while 30.3% recommend Hold. The average price target is $477.25, which gives an upside of 27.6% from the current price.

Consensus: Buy (4.03/5)
Strong Buy
14 (42.4%)
Buy
8 (24.2%)
Hold
10 (30.3%)
Strong Sell
1 (3%)
Strong Sell Sell Hold Buy Strong Buy
4.03 out of 5 based on 33 analysts

About Intuitive Surgical – Medicinsk udstyr

Intuitive Surgical, Inc. laver udstyr, der hjælper læger med at udføre avancerede operationer, hvor de kun skal lave små snit. De tjener primært penge på at sælge deres robotsystemer og tilhørende instrumenter. Deres mest kendte produkt er da Vinci Surgical System, som bruges til kompleks kirurgi. De har også Ion endoluminal systemet, der bruges til diagnostik, især i lungerne. Intuitive Surgical sælger deres udstyr til hospitaler både i USA og internationalt. De leverer også en komplet servicepakke, der inkluderer installation, teknisk support døgnet rundt og vedligeholdelse. De har desuden solgt over 7.500 da Vinci-systemer globalt. Read more about the company

Key Figures for Intuitive Surgical

$ 132B Market cap
$ 11,0B Revenue
Medicinsk udstyr Industry
39.73 P/E
11.96 P/S
6.87 P/B
USA Listed on exchange
Sundhed Sector

What kind of stock is Intuitive Surgical?

Growth stock Quality stock

Intuitive Surgical is classified as a growth stock and quality stock. This means the stock combines several attractive traits, strong financial health (Piotroski 7/9).

Score Overview for Intuitive Surgical

💰 Value Score 23/100 (Low)
⭐ Quality Score 88/100 (Very High)
🚀 Momentum Score 19/100 (Very Low)
📊 Total Score 43/100

📈 Valuation

Intuitive Surgical trades at a P/E ratio of 39.7, which is above the market average. The forward P/E is 32.8 (17% lower), which suggests the market expects rising earnings. The P/S ratio is 12.0 (high — the market pays a premium for the revenue). The P/B ratio is 6.9. The PEG ratio is 1.73.

💵 Profitability & Growth

Intuitive Surgical has a profit margin of 28.5% (excellent) and an operating margin of 33.6%. Return on equity (ROE) is 17.4% — solid return on equity. Return on assets (ROA) is 10.5%. The latest quarterly earnings grew 26.5% year over year — strong growth.

🏦 Financial Health

The Piotroski score is 7 out of 9 — good financial health. Altman Z2 is 12.06 (healthy balance sheet — low risk). The debt-to-equity ratio (D/E) is 14.1% — low debt, a solid balance sheet.

🚀 Momentum & Short Interest

Short interest is 1.90% — low, the market does not expect a decline.

Insider Trading in Intuitive Surgical 2026: The Signal Is negative

In 2026, insiders at Intuitive Surgical have made 20 transactions, all of which were sales. On a net basis, insiders took 4,217,266 $ out of the stock. Active insiders include Brosius Mark, Rosa David J., LOEB GARY and others. In the short term (last 3 months), the insider signal is negative.

Short-Term Signal (3 months): Negative

Insiders have exclusively sold shares over the last 3 months.

Over the last 3 months: 0 purchases and 20 sales. A net 4,217,266 $ out of the stock.

Long-Term Signal (all transactions): Negative

Insiders have exclusively sold shares in the recent period. This can suggest management sees limited opportunity.

Across the last 20 transactions: 0 purchases and 20 sales. A net 4,217,266 $ out of the stock.

Latest sale: Brosius Mark sold 28 shares at 351 $ each on 2026-07-31.

Who is selling: Brosius Mark, Rosa David J., LOEB GARY, Jeddi Iman.

Latest Insider Trades in Intuitive Surgical (2026)

The table shows the last 20 reported insider transactions in Intuitive Surgical. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share ($) Total amount ($)
2026-07-31 Brosius Mark Sell 28 351 9,828
2026-07-30 Brosius Mark Sell 28 347 9,711
2026-07-29 Brosius Mark Sell 28 360 10,086
2026-07-28 Brosius Mark Sell 28 366 10,236
2026-07-27 Brosius Mark Sell 28 344 9,632
2026-07-10 Rosa David J. Sell 1,910 412 786,061
2026-06-12 Brosius Mark Sell 25 414 10,353
2026-06-11 Brosius Mark Sell 23 412 9,480
2026-06-10 Rosa David J. Sell 1,358 427 579,336
2026-06-10 LOEB GARY Sell 400 424 169,656

Who is buying and selling Intuitive Surgical shares in 2026?

The following insiders have sold shares: Brosius Mark, Rosa David J., LOEB GARY, Jeddi Iman. In total, 4,217,266 $ was sold across 20 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

Intuitive Surgical Short Selling 2026: 1.9% Sold Short

Low short interest: 1.9% of the free float
Short % of free float
1.9%
Assessment
Low short interest
Short squeeze risk
Low
Data source
SEC
Updated daily
The stock has a low share of short selling. Less than 2% of the freely traded shares are sold short, which points to limited bearish sentiment.

Data is updated daily based on official filings with the SEC.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
1.9%

When Does Intuitive Surgical Report Earnings – Next Date: 10/20/2026

The next earnings report from Intuitive Surgical is scheduled for October 20, 2026, after the market closes. This report covers the third quarter (Q3), which ended on September 30, 2026.



Technical Analysis of Intuitive Surgical 2026 – Signal: Strong Sell

Overall Technical Signal: Strong Sell

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated August 6, 2026.

Technical analysis of Intuitive Surgical (ISRG.US) – RSI 50, MACD negative (bearish), daily candlestick chart August 2026
Intuitive Surgical technical analysis – candlestick chart with RSI and MACD. Updated Aug 6, 2026.

Trend Analysis of Intuitive Surgical, Inc

Intuitive Surgical, Inc is in a short-term uptrend. The price of $375.20 is 2.1% above the 20-day average ($367.60). Medium term, the picture is negative: the price is 5.1% below the 50-day average ($395.23). Long term, the stock is 22.0% below the 200-day average ($480.94), which signals a long-term downtrend.

Death Cross: The 50-day average (395.23) is below the 200-day average (480.94), which is a classic bearish signal for Intuitive Surgical, Inc.

Is Intuitive Surgical, Inc overbought or oversold?

Intuitive Surgical, Inc has an RSI of 49.8, right in the middle of the neutral zone. There is no clear buying or selling pressure.

MACD Analysis for Intuitive Surgical, Inc

Daily MACD: MACD is negative (-10.342), which means the short-term trend is bearish (the 12-day EMA is below the 26-day EMA). MACD is above the signal line (-14.101) by 3.759, which suggests the negative momentum is fading – a potential trend reversal could be ahead.

Weekly MACD: MACD5 is negative (-34.138), which indicates a broader bearish long-term trend. MACD5 is below the signal line (-27.452) by 6.686, which confirms continued negative long-term momentum.

Overall MACD assessment: Both the daily and weekly trend are bearish (MACD negative). However, momentum shows signs of improving on a daily basis – a potential trend reversal could be ahead, but it is not confirmed yet.

Risk Profile for Intuitive Surgical, Inc

Intuitive Surgical, Inc has an annual standard deviation of 36.4%, which classifies the stock as medium risk. The price can swing noticeably when the market moves.

Overall Technical Conclusion for Intuitive Surgical, Inc

Trend: Negative. The price trades below SMA50 and SMA200.

MACD trend (zero line): Daily bearish (-10.342). Weekly bearish (-34.138).

MACD momentum (signal): Daily rising. Weekly falling.

RSI: 49.8 – neutral.

Technical signal: Strong Sell

The price is in a downtrend (below SMA50/SMA200) and MACD is negative on both a daily and weekly basis. Avoid buying and consider closing existing positions.

Frequently Asked Questions About Intuitive Surgical stock in 2026

Should you buy Intuitive Surgical stock now?
No, the technical signal for Intuitive Surgical is currently SELL. Intuitive Surgical trades at $373.98 as of 8/6/2026. The overall technical signal is: Strong Sell. The technical analysis shows the following: MACD is negative (bearish trend) at -10.342 with rising momentum (signal: -14.101); RSI is at 49.8 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $477.25 points to 27.6% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Intuitive Surgical stock?
The average analyst price target for Intuitive Surgical is $477.25. The current price is $373.98, which gives an upside of 27.6%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $429.53 and $524.98.
Is Intuitive Surgical a dividend stock?
No, Intuitive Surgical does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Intuitive Surgical stock?
Intuitive Surgical is rated as a stock with moderate risk. the annual standard deviation is 36.4%, which classifies the stock as moderate risk.
Is Intuitive Surgical overvalued?
No, Intuitive Surgical is considered undervalued based on the analyst price target (27.6% upside). Intuitive Surgical has the following valuation ratios: a P/E ratio of 39.7 (highly valued), a P/S ratio of 12.0, a P/B ratio of 6.9. The analyst price target suggests that the stock is undervalued by 27.6%.
Is Intuitive Surgical overbought?
No, Intuitive Surgical is not overbought. RSI is at 49.8 (neutral zone). The technical indicators show: RSI is at 49.8 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 1.7% above the 20-day average (short-term uptrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Intuitive Surgical earnings report?
Intuitive Surgical reports its next earnings on October 20, 2026. The stock currently trades at $373.98. With a P/E ratio of 39.7, the market will be watching closely whether earnings meet expectations.
Is Intuitive Surgical shorted?
Yes, Intuitive Surgical is shorted with 1.9% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. Data is updated daily based on official filings with the SEC.
Are insiders buying Intuitive Surgical stock?
No, insiders are not buying Intuitive Surgical shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 20 sales. On a net basis, 4,217,266 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 4,217,266 $ sold. Active sellers include Brosius Mark, Rosa David J., LOEB GARY and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Intuitive Surgical a good stock?
Based on our total score, Intuitive Surgical is rated as a mediocre stock with a total score of 43 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 23/100, Quality: 88/100, Momentum: 19/100. In addition: analysts see 27.6% upside to the price target; technical signal: Strong Sell. Whether Intuitive Surgical is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Intuitive Surgical stock?
The outlook for Intuitive Surgical based on current data: the average analyst price target is $477.25 (+27.6%); the stock is in a downtrend (below SMA50 and SMA200); the next earnings report is due on 10/20/2026, which can move the price; the P/E ratio is 39.7 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Intuitive Surgical stock moving?
Intuitive Surgical is stable right now. The technical indicators show: the price is close to the 20-day average; insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Intuitive Surgical go?
The average analyst price target for Intuitive Surgical is $477.25, which corresponds to a potential gain of 27.6% from the current price of $373.98. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Intuitive Surgical fall?
We lack enough history to give a specific floor for Intuitive Surgical. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Intuitive Surgical do?
Intuitive Surgical, Inc. laver udstyr, der hjælper læger med at udføre avancerede operationer, hvor de kun skal lave små snit. De tjener primært penge på at sælge deres robotsystemer og tilhørende instrumenter. Deres mest kendte produkt er da Vinci Surgical System, som bruges ... The company belongs to the Sundhed sector, more specifically the Medicinsk udstyr industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Intuitive Surgical as an investment.
Did Intuitive Surgical raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Intuitive Surgical. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Intuitive Surgical making money or losing money?
Yes, Intuitive Surgical is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 28.5% — which is excellent. The operating margin (profit before interest and taxes) is 33.6%. At a P/E ratio of 39.7, you currently pay 39.7 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Intuitive Surgical go bankrupt?
The bankruptcy risk of Intuitive Surgical is rated as low. Altman Z2 (a model for assessing financial distress) is 12.06 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 7 — which is strong. Debt relative to equity is 14% (low). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Intuitive Surgical have a lot of debt?
No, Intuitive Surgical has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 14%. For the sundhed sector, anything below 80% counts as low debt. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.